Positioning Statements on Physician-led Switching for Biosimilar Medicines

19 September 2019

Policy

Positioning Statements on Physician-led Switching for Biosimilar Medicines BIOSIMILAR MEDICINES […]

Open letter to the Members of the European Parliament on the importance to sustain EU progress in fighting against antimicrobial resistance (AMR)

11 September 2019

Policy

Medicines for Europe Commentary on the Draft EMA regulatory science strategy 2025

28 June 2019

Policy

How can your healthcare system support a wider access to Value Added Medicines?

27 May 2019

Infographic

Annual Medicines for Europe and IGBA Conference 2019

4 April 2019

Video

Infographic: Value Added Medicines Provide a Wide Range of Different and Important Benefits to Patients, Healthcare Professionals and Healthcare Systems

3 April 2019

Infographic

Calls to action to improve access to value added medicines

26 February 2019

Policy, Report

Case Studies for Value Added Medicines. Unlocking the potential of patient-centric continuous innovation

26 February 2019

Policy, Report

15^th Legal Affairs Conference

14 December 2018

Video

17^th Biosimilar Medicines Conference

16 November 2018

Video